RECRUITING

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Talk to us

Conditions

Cervical Large Cell Neuroendocrine CarcinomaCervical Neuroendocrine CarcinomaCervical Small Cell CarcinomaCervical Undifferentiated CarcinomaStage I Cervical Cancer AJCC v8Stage IA Cervical Cancer AJCC v8Stage IA1 Cervical Cancer AJCC v8Stage IA2 Cervical Cancer AJCC v8Stage IB Cervical Cancer AJCC v8Stage IB1 Cervical Cancer AJCC v8Stage IB2 Cervical Cancer AJCC v8Stage II Cervical Cancer AJCC v8Stage IIA Cervical Cancer AJCC v8Stage IIA1 Cervical Cancer AJCC v8Stage IIA2 Cervical Cancer AJCC v8Stage IIB Cervical Cancer AJCC v8Stage III Cervical Cancer AJCC v8Stage IIIA Cervical Cancer AJCC v8Stage IIIB Cervical Cancer AJCC v8Stage IV Cervical Cancer AJCC v8Stage IVA Cervical Cancer AJCC v8Stage IVB Cervical Cancer AJCC v8

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.

Official Title

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Quick Facts

Study Start:2013-05-16
Study Completion:2044-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04723095

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with a personal history of cervical cancer with any portion of neuroendocrine component (including mixed tumors) of the following histologic subtypes:
  2. * Small cell neuroendocrine carcinoma
  3. * Large cell neuroendocrine carcinoma
  4. * Undifferentiated high-grade neuroendocrine carcinoma
  5. * Patients may be in any stage of treatment, surveillance or recurrence at the time of initial participation in the study
  6. * Patients with all stages of disease are considered eligible
  7. * Patients who do not speak English can be eligible if accompanied by an institutional interpreter
  8. * Patients who are receiving or have received treatment at any facility, including but not limited to M. D. Anderson Cancer Center are eligible
  9. * Patient may be residents of any country and be of any ethnic background
  10. * Patients who request to participate in the study, regardless of the method by which they learned of it, are eligible to participate, including, but not limited to patients who seek participation via the website
  11. * Next of kin or legal authorized representatives of patients who are deceased but had a history of neuroendocrine carcinoma (NEC) of the cervix are eligible to participate
  12. * Next of kin or legal authorized representatives of patients must read and speak English
  1. * Patients with other histologic subtypes of NEC of the cervix including typical and atypical carcinoid tumors

Contacts and Locations

Study Contact

Michael M. Frumovitz
CONTACT
713-792-9599
nectur@mdanderson.org

Principal Investigator

Michael M Frumovitz
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Michael M Frumovitz, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2013-05-16
Study Completion Date2044-01-01

Study Record Updates

Study Start Date2013-05-16
Study Completion Date2044-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cervical Large Cell Neuroendocrine Carcinoma
  • Cervical Neuroendocrine Carcinoma
  • Cervical Small Cell Carcinoma
  • Cervical Undifferentiated Carcinoma
  • Stage I Cervical Cancer AJCC v8
  • Stage IA Cervical Cancer AJCC v8
  • Stage IA1 Cervical Cancer AJCC v8
  • Stage IA2 Cervical Cancer AJCC v8
  • Stage IB Cervical Cancer AJCC v8
  • Stage IB1 Cervical Cancer AJCC v8
  • Stage IB2 Cervical Cancer AJCC v8
  • Stage II Cervical Cancer AJCC v8
  • Stage IIA Cervical Cancer AJCC v8
  • Stage IIA1 Cervical Cancer AJCC v8
  • Stage IIA2 Cervical Cancer AJCC v8
  • Stage IIB Cervical Cancer AJCC v8
  • Stage III Cervical Cancer AJCC v8
  • Stage IIIA Cervical Cancer AJCC v8
  • Stage IIIB Cervical Cancer AJCC v8
  • Stage IV Cervical Cancer AJCC v8
  • Stage IVA Cervical Cancer AJCC v8
  • Stage IVB Cervical Cancer AJCC v8